← Feed📈 Board🎯 Predictions🚧 Bottlenecks📐 Calibration📊 AnalysisLEU Thesis2026-10-23 12:00 PM · Centrus Energy Corp. Class A

LEU — Centrus Energy Corp. Class A

$103.59-0.56 (-0.54%)
Open 101.18 · High 103.67 · Low 100.97 · Vol 739,947
Delayed quote · 2026-10-23 11:00 AM · change vs prev close · source: Stooq
Running conviction (P)
0.75prior 0.65

Investment Read as of 2026-10-19

The Read

LEU is a SOLID investment. Its position as the sole US HALEU producer creates an irreplaceable choke point for next-generation nuclear power. This structural monopoly remains intact, supporting the high conviction of P=0.75.

Bull case

Bear case / what breaks it

What the latest signal says

The 8-K filing provides concrete operational updates, which reinforces the company’s progress toward achieving critical output milestones. These filings are necessary proof points that the physical execution of the monopoly remains on track [Source].

Posterior history

DatePΔCallDriver
2026-10-190.75+0.05UP/MEDAEP signed a deal for a 960 MW advanced nuclear plant in Indiana with Amazon and X-energy.
2026-10-090.70-0.02REVIEW/-Stable. The recent good news is all about future demand: more reactors planned, faster lic
2026-10-040.72+0.02UP/LOWAll six New England states convened to back new nuclear development — state-level demand p
2026-10-020.70-0.05REVIEW/-Stable, not strengthening — the demand pillar genuinely improved, but every uptick since 2
2026-09-290.75+0.05UP/MEDTVA's big nuclear project got the green light, alongside a permitting-reform deal. The wea
2026-09-250.70-0.03REVIEW/-Stable. The pillars that actually carry this thesis — Centrus's own enrichment position, t
2026-09-240.73+0.05UP/MEDNRC opened a wholesale rewrite of reactor licensing, decommissioning and oversight rules u
2026-09-220.68+0.05UP/MEDKairos picks Samsung C&T to build a 50MW SMR for Google in Tennessee by 2030 — a named EPC
2026-09-180.63-0.07REVIEW/-Weakening. The only genuinely new pillar-level evidence this fortnight was negative — two
2026-09-180.70+0.05UP/MEDTwo offsets to Monday–Thursday's Holtec damage: the uranium market is described as sliding
2026-09-170.65-0.07DOWN/MEDPomerantz opened a securities investigation into NuScale — the flagship US SMR name and a
2026-09-170.72-0.07DOWN/MEDHoltec — an SMR developer, not a fringe name — pulled its US IPO, blaming AI-trade turbule

Thesis detail

Core thesis

The only US producer of HALEU — the enriched fuel next-gen and small modular

reactors require. With Russian SWU banned, domestic enrichment is a strategic

monopoly in front of a multi-decade demand wave. Binary, but the option is on an

irreplaceable chokepoint.

Pillars (with priors)

1. Sole US HALEU enricher (~900 kg/yr vs. 50+ MT/yr projected 2030 demand) · P = 0.75

2. Russian SWU ban (phased to 2028/2040) removes ~30–45% of global supply · P = 0.80

3. DOE funding underwrites domestic enrichment expansion · P = 0.55

4. SMR / advanced-reactor pipeline = the HALEU demand curve · P = 0.50

Expected news (the prior)

Surface the residual: a second domestic enricher at scale, a funding cut,
or SMR timelines slipping is the signal.

Thesis-breaking triggers (→ set P near 0)

Leading vs lagging indicators

Key metrics

Valuation anchor

Binary, ~1.5:1 skew (≈ −50/−70% vs. +60/+100%). Lottery-ticket sizing on a

monopoly, per the sizing rules.

Cross-arena sensors

B2 (nuclear fuel/SMR), B7 (Russia ban/sanctions, enrichment policy).

Posterior log